Macroaxis provides investment recommendation on IHS Markit to complement and cross-verify current
analyst consensus on IHS Markit. Our trade recommendations engine determines the entity's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. About
91.0% of the company shares are owned by institutional investors. The book value of IHS Markit was currently reported as 21.57. IHS Markit has Price/Earnings To Growth (PEG) ratio of 2.99. The entity last dividend was issued on the 29th of October 2020. The firm had
1:4 split on the 13th of July 2016.
Use Technical Analysis to project IHS expected Price
IHS Markit technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of IHS Markit technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of IHS Markit trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions.
More Info...What is driving IHS Markit Investor Appetite?
The company reported the previous year's revenue of 4.3
B. Net Income was 922.7
M with profit before overhead, payroll, taxes, and interest of 2.76
B.
| 2017 | 2018 | 2020 | 2021 (projected) |
Cost of Revenue | 1.5 B | 1.66 B | 1.91 B | 1.7 B | Consolidated Income | 539.2 M | 499.4 M | 169.05 M | 258.5 M |
Deferred Revenue Breakdown
IHS Markit Deferred Revenue yearly trend continues to be quite stable with very little volatility. Deferred Revenue may rise above about 210
M this year. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. IHS Markit Deferred Revenue is quite stable at the moment as compared to the past year. The company's current value of Deferred Revenue is estimated at 209.97 Million
| 2010 | 552.5 Million |
| 2013 | 177.9 Million |
| 2015 | 770.2 Million |
| 2016 | 790.8 Million |
| 2017 | 886.8 Million |
| 2018 | 879.7 Million |
| 2020 | 204.59 Million |
| 2021 | 209.97 Million |
IHS Markit has 52 percent chance to slide under $89 in the coming weeks
Latest Total Risk Alpha is up to -0.06. Price may slide again. IHS Markit has relatively low volatility with skewness of 0.54 and kurtosis of 5.72. However, we advise all investors to independently investigate IHS Markit to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns.
The Current Takeaway on IHS Markit Investment
Whereas many other companies in the consulting services industry are either recovering or due for a correction, IHS Markit may not be performing as strong as the other in terms of long-term growth potentials. To summarize, as of the 13th of January 2021, we believe that IHS Markit is currently
undervalued with
low chance of distress in the next two years. Our present 30 days buy-or-sell advice on the company is
Buy.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of IHS Markit. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
